A nurse is assessing a client who has muscarinic agonist poisoning. Following administration of atropine, which of the following findings should indicate to the nurse that the treatment has been effective?

C. This situation involves a medication error where the roommate mistakenly takes a medication intended for another client. Medication errors, including administration to the wrong client, are serious incidents that require immediate documentation through an incident report. This ensures proper investigation, implementation of corrective actions, and monitoring for potential harm to the client who received the medication in error.

A. Adjusting medication administration times based on client preference or clinical appropriateness does not typically require an incident report. It is part of routine nursing care and can be managed through communication with the healthcare team and documentation in the client's record.

B. The client experiencing an unpleasant taste after taking medication suggests a possible adverse reaction or side effect. While this situation warrants assessment and documentation of the client's response, it does not necessarily indicate an incident requiring an incident report unless the symptom is severe or indicates a potential medication issue requiring further investigation.

D. Client refusal of medication is a common occurrence and can happen for various reasons such as personal preference, fear of side effects, or misunderstanding. Client refusal of medication, while

important to document in the client's record, does not usually require an incident report unless there are significant concerns about the client's safety or the refusal leads to a serious outcome that needs further investigation.

B. Endocarditis is an infection of the inner lining of the heart chambers and valves, usually caused by bacteria entering the bloodstream. Treatment typically involves antibiotics that can penetrate into heart tissues to eradicate the infection.

A. Kidney transplant recipients are at risk for infections, particularly from immunosuppressive therapy that reduces their ability to fight off pathogens. Metronidazole is not commonly indicated.

C. Metronidazole can rarely cause neurotoxic side effects, including seizures, particularly with high doses or prolonged use. It is not used to treat seizures, and its use should be carefully monitored in patients with a history of seizures or neurological disorders.

D. Hypokalemia is a metabolic disorder that requires correction of potassium levels through appropriate supplementation or treatment of the underlying cause. Metronidazole is used for infections and does not play a role in managing electrolyte abnormalities like hypokalemia.